In the spring of 2009, a new strain of influenza, originally called “swine flu” but later scientifically categorized as H1N1, caused widespread and continuing outbreaks in the northern and southern hemispheres. The rate at which new H1N1 information and guidelines have emerged is almost unprecedented.
Anticipating the information needs of healthcare organizations and professionals across disciplines, Elsevier Clinical Decision Support delivers accurate, evidence-based and actionable information whenever and wherever needed within the healthcare workflow. From concise answers to in-depth information, from interactive task guidance to real-time data analysis, Elsevier provides a spectrum of knowledge for advancing healthcare.
FOR PHYSICIANS
H1N1 FAQs on First Consult. First Consult is an authoritative evidence-based and continuously updated clinical information resource for healthcare professionals. Where did H1N1 come from and what makes it a pandemic virus? Board-certified Internal Medicine and Infectious Disease expert Dr. Hessen answers the H1N1 questions healthcare professionals ask most. It’s just one example of information you’ll find at First Consult, including quick reference on evaluation, diagnosis, clinical management, prognosis, and prevention for use at the point of care.
Read the full FAQ at www.mdconsult.com/h1n1.html
More information about First Consult
FOR NURSES
Mosby’s Nursing Consult features a vast array of H1N1 information and resources to help you in your nursing practice, including:
More information is available at Nursing Consult.
FOR PHARMACISTS
Clinical Pharmacology offers access to a H1N1 page featuring links to the latest FDA, CDC and WHO updates. Several documents are available for reference, including: “A Pharmacist’s Guide to Pandemic Flu Preparedness”, prepared by the NACDS Foundation, the American Pharmacist’s Association, and the American Society of Health-System Pharmacists; and “Pandemic Influenza Planning Checklist for Ambulatory Clinics and Medical Offices”, prepared by HHS and CDC.
Clinical Pharmacology is updated in “real-time” to reflect the latest updates from the FDA and CDC as well as product availability for the H1N1 virus vaccine as well as medications used to treat H1N1 infection.
The most vulnerable groups to H1N1 include: Pregnant women; health care workers; children and young adults from 6 months to 24 years; and people aged 25 to 64 years with underlying medical conditions.
Current subscribers login now for complete details regarding risks and treatment protocols.
Overview of the H1N1 vaccines and antiviral drugs used to treat the H1N1 influenza infection.
